45
Participants
Start Date
November 30, 2010
Primary Completion Date
March 31, 2011
Study Completion Date
March 31, 2011
varenicline free base patch
varenicline transdermal delivery system (12.0 mg payload \[drug amount loaded in each patch\]) will be applied to the skin once daily for 14 days
varenicline free base patch
varenicline transdermal delivery system (18.0 mg payload \[drug amount loaded in each patch\]) will be applied to the skin once daily for 14 days
placebo patch
Matched placebo transdermal delivery system will be applied to the skin once daily for 14 days
varenicline free base patch
varenicline transdermal delivery system (24.0 mg payload \[drug amount loaded in each patch\]) will be applied to the skin once daily for 14 days
placebo patch
Matched placebo transdermal delivery system will be applied to the skin once daily for 14 days
varenicline free base patch
2 varenicline transdermal delivery systems (combined to achieve a maximum drug payload of 36 mg) will be applied to the skin, side by side once daily, for 14 days
placebo patch
Matched placebo transdermal delivery systems will be applied to the skin, side by side, once daily for 14 days
Pfizer Investigational Site, Fargo
Lead Sponsor
Pfizer
INDUSTRY